Jupiter Life Line Hosp L
NSE: JLHL · Hospital · sector
₹252.95NSE close 2026-10-26
Key numbers
Market cap₹8,291 cr
Price₹252.95
52w high / low₹340 / ₹235
P/E44.2xSector median 42.5x
P/B5.4xSector median 4.9x
Book value₹47.1
Dividend yield0.08%Sector median 0.17%
ROE13.0%Sector median 12.1%
ROCE13.9%Sector median 13.8%
OPM21.7%Sector median 20.3%
Debt / equity0.33xSector median 0.24x
EV/EBITDA24.4xSector median 23.6x
Interest cover7.7x
Current ratio3.02x
Sales growth 3y–Sector median +14.1%
Profit growth 3y–Sector median +14.7%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹544 cr vs borrowings ₹509 cr (FY26): cash is higher (net cash).
- Operating profit covered interest 7.7x in the last 12 months.
- Operating cash flow was below net profit in 1 of the last 3 years (FY24).
- Revenue was higher than a year earlier in 4 of the last 4 quarters.
- Other income was 21% of net profit in the last 12 months.
- Dividend paid in 2 of the last 3 financial years.
- Price ₹252.95 on 2026-10-26: -25.6% from the 52-week high, +7.7% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹327.10 · low ₹247.05
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 323 | 321 | 327 | 348 | 394 | 365 | 388 | 411 |
| EBITDA | 75 | 75 | 78 | 78 | 92 | 77 | 89 | 79 |
| OPM % | 23.2% | 23.4% | 23.9% | 22.5% | 23.4% | 21.1% | 23.0% | 19.3% |
| Other income | 9 | 8 | 7 | 13 | 11 | 9 | 9 | 11 |
| Net profit | 52 | 53 | 45 | 44 | 57 | 43 | 51 | 37 |
| EPS (₹) | 1.57 | 1.60 | 1.37 | 1.34 | 1.75 | 1.30 | 1.53 | 1.14 |
| Revenue YoY | +22.0% | +14.0% | +18.7% | +18.2% | ||||
| Profit YoY | +11.3% | -19.0% | +12.8% | -14.5% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|
| Revenue | 1,070 | 1,262 | 1,500 | 1,558 |
| EBITDA | 238 | 297 | 343 | 338 |
| Net profit | 177 | 193 | 194 | 188 |
| EPS (₹) | 5.73 | 5.89 | 5.92 | 5.72 |
| Revenue growth | +18.0% | +18.9% | +18.2% | |
| Profit growth | +9.4% | +0.6% | -2.4% | |
| Dividend / share (₹) | – | 1.00 | 1.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | +18.2% |
| Net profit | – | – | -2.4% |
| EPS | – | – | – |
| Share price | – | -4.6% (2y) | -21.0% |
Balance sheet
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Shareholders' equity | 1,169 | 1,356 | 1,544 |
| Borrowings | 0 | 326 | 509 |
| Cash & equivalents | 318 | 603 | 544 |
| Total assets | 1,281 | 1,905 | 2,383 |
| Fixed assets | 716 | 973 | 1,376 |
| Capital work in progress | 74 | 185 | 129 |
| Investments | 0 | 0 | 0 |
| Receivables | 57 | 42 | 76 |
| Inventory | 21 | 24 | 38 |
| Payables | 62 | 103 | 96 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash from operations | 115 | 253 | 268 |
| Cash from investing | -76 | -209 | -442 |
| Cash from financing | 128 | 301 | 136 |
| Capex | 85 | 321 | 502 |
| Free cash flow | 29 | -67 | -234 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| ROE % | 15.1% | 14.2% | 12.6% |
| ROCE % | 19.0% | 15.9% | 14.5% |
| Debtor days | 20 | 12 | 18 |
| Inventory days | 41 | 38 | 49 |
| Payable days | 120 | 163 | 121 |
| Cash conversion cycle (days) | -59 | -113 | -54 |
| Working capital days | 104 | 155 | 112 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 40.91% |
| FIIs | 9.13% |
| DIIs | 19.13% |
| of which Mutual funds | 13.45% |
| of which Insurance | 2.10% |
| Public (non-institutions) | 30.83% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% | 40.91% |
| Promoter group | % |
|---|---|
| Ajay Pratap Thakker | 20.74% |
| Western Medical Solutions LLP | 8.70% |
| Ankit Ajay Thakker | 6.67% |
| Gandhi Neeta Devang | 2.10% |
| Kirtika Ajay Thakker | 2.03% |
| Devang Vasantlal Gandhi | 0.63% |
| Nikita Ankit Thakker | 0.02% |
| Ajay Pratap Thakker HUF | 0.01% |
| Sanjay Thakker | 0.00% |
| Roopa Ganatra | 0.00% |
| AVI Thakker | 0.00% |
| Amit Jain | 0.00% |
| Neera Jain | 0.00% |
| Abhinav Jain | 0.00% |
| Ankita Jain | 0.00% |
| Public holders above 1% | % |
|---|---|
| SBI Healthcare Opportunities Fund | 7.43% |
| HDFC Mutual Fund - HDFC Multi CAP Fund | 3.46% |
| JM Financial Products Limited | 3.42% |
| Goldman Sachs Funds - Goldman Sachs India Equity P | 2.75% |
| Mihir Wire Industries LLP | 2.15% |
| SBI Life Insurance Co. Ltd | 2.10% |
| DR Navin Ramji Davda | 2.00% |
| J M Financial and Investment Consultancy Servicesprivate Limited | 1.91% |
| Ramakant Jagdish Tibrewala | 1.87% |
| Brijesh Ramakant Tibrewala | 1.80% |
| Mahesh Ramakant Tibrewala | 1.80% |
| Mitul Nitin Thakker | 1.52% |
| SNK Investments Private Limited | 1.39% |
| Sushma Ramakant Tibrewala | 1.22% |
| Rajesh Hiralal Vora | 1.14% |
33,255 shareholders. Pledged: – of promoter shares.
Peers in Hospital
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| APOLLOHOSP | ₹1,12,797 cr | 54.0x | 11.9x | 23.6% | 21.8% | 15.1% | +14.9% | 0.26% |
| MAXHEALTH | ₹81,266 cr | 55.7x | 7.6x | 14.5% | 13.8% | 26.1% | +22.4% | 0.18% |
| MANIPALHOS | ₹73,581 cr | – | – | – | – | – | – | – |
| FORTIS | ₹55,467 cr | 52.9x | 5.6x | 11.1% | 13.2% | 22.2% | +13.2% | 0.14% |
| NH | ₹33,971 cr | 41.4x | 7.5x | 20.0% | 13.7% | 18.7% | +20.4% | 0.26% |
| ASTERDM | ₹33,523 cr | 104.7x | 7.3x | 8.0% | 12.8% | 16.7% | -27.0% | 0.16% |
| MEDANTA | ₹32,575 cr | 58.5x | 8.2x | 15.1% | 15.8% | 20.5% | +17.9% | 0.04% |
| KIMS | ₹28,123 cr | 131.3x | 12.5x | 9.3% | 9.6% | 19.5% | +21.1% | 0.74% |
| AGARWALEYE | ₹15,065 cr | 101.3x | 7.4x | 7.6% | 16.5% | 27.8% | – | 0.01% |
| JLHL | ₹8,291 cr | 44.2x | 5.4x | 13.0% | 13.9% | 21.7% | – | 0.08% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-07-24 | Split | Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share |
| 2026-05-22 | Dividend | Interim Dividend - Re 1 Per Share |
| 2025-07-04 | Dividend | Dividend - Re 1 Per Share |
| 2024-08-02 | Dividend | Dividend - Re 1 Per Share |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY24
- Announcements NSE filings
- BRSR FY26
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
- Hospital and Medical Healthcare (Healthcare Services): Hospital activities
| Sector | Healthcare |
| Industry | Hospital |
| Sub-industry | Hospital |
| Symbol | JLHL |
| BSE code | 543980 |
| ISIN | INE682M01020 |
| Face value | ₹2.0 |
| Incorporated | 2002-11-18 |
| Website | www.jupiterhospital.com |
| Plants (India / abroad) | 5 / 0 |
From the company's filings (BRSR FY26).
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.